Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook
Open Access
- 1 August 1998
- journal article
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 1998 (24) , 1-28
- https://doi.org/10.1093/oxfordjournals.jncimonographs.a024182
Abstract
Clinical economics is a new and evolving discipline that addresses the economic implications of changes in medical practice. As applied to cancer care, clinical economics assesses the costs and effectiveness of new cancer interventions and can be a valuable endpoint in selected clinical trials. Through the integration of economics into clinical evaluations, information can be developed that contributes to the decisions of patients, clinicians, health care managers, and policymakers as to the most effective allocation of cancer care resources.Keywords
This publication has 54 references indexed in Scilit:
- Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.Journal of Clinical Oncology, 1997
- Recommended breast cancer surveillance guidelines. American Society of Clinical Oncology.Journal of Clinical Oncology, 1997
- Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapyBMJ, 1996
- Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1996
- The Purpose of Advance Medical Planning — Autonomy for Patients or Limitation of Care?New England Journal of Medicine, 1996
- Cost-effective models for flutamide for prostate carcinoma patients: Are they helpful to policy makers?Cancer, 1996
- American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.Journal of Clinical Oncology, 1994
- Controversies in Treatment: How can hospitals ration drugs? Drug rationing in a teaching hospital: a method to assign prioritiesBMJ, 1994
- Efficacy and Cost-effectiveness of Autologous Bone Marrow Transplantation in Metastatic Breast CancerJAMA, 1992
- Clinical EconomicsJAMA, 1989